Projeto Portugal 2020

Frontiers of technology for theranostics of cancer, metabolic and neurodegenerative diseases (FROnTHERA)

Nesta página

Ficha de projeto
Beneficiários do financiamento
Distribuição geográfica do financiamento

Ficha de projeto

Nome

Frontiers of technology for theranostics of cancer, metabolic and neurodegenerative diseases (FROnTHERA)

Valor de financiamento

2,95 milhões €

Valor executado

2,68 milhões €

Código de operação

NORTE-01-0145-FEDER-000023

Data de conclusão

29.10.2020

Sumário

3B’s Research Group, the International Iberian Nanotechnology Laboratory- INL, and ICVS decide to combine expertizes in tissue engineering, medical sciences and nonotechnologies in order to developed an ambitious project for the development of novel therapeutic and diagnostic tools aimed for treating cancer, metabolic and neurodegenerative diseases.